By Dan Bancroft & Steven Porter
news@seacoastonline.com
YORK, Maine Two vaccines for COVID-19 have been approved thus far for widespread U.S. distribution, but a third could be approved before too long, perhaps with some help from local volunteers.
Tens of thousands of people have rolled up their sleeves for the ongoing clinical trials to test AstraZeneca s vaccine candidate, which researchers say has shown promising preliminary signs of being effective against the virus that has infected millions globally in the past year.
York residents Kim and Barry Waddell, who are among those to participate in an AstraZeneca trial, are slated to receive the second of their two shots on New Year s Eve. In the current study, the vaccine is administered in two shots 30 days apart.